Finding colorectal cancer early with a blood test and app
Part of Cancer, Digestive system clinical trials.
This study tests a new blood test for early detection of colorectal cancer in people at average risk. It aims to make screening easier and more accessible through a smartphone app.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 84 years old.
- Your doctor considers you to be at average risk for colorectal cancer.
- You do not currently have symptoms like blood in your stool.
- You haven't had a recent colorectal cancer screening (within the past year for some tests, or within 10 years for a colonoscopy).
- You have a MyBSW portal account or are willing to create one.
- You are willing and able to give a blood sample.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a mobile app designed to help improve the quality of colonoscopies for people in a colorectal cancer screening program. If you have had a positive FIT test and are between 50 and 69, you may be able to join.
This study is testing a new blood test that might help find cancer early. If you are 40 or older and planning a routine screening colonoscopy, you may be able to join. You will give a blood sample before the colonoscopy, and the researchers will see if the test can detect signs of cancer.
This study is testing a new blood test (Signal-C) to see if it can help find colorectal cancer early. You may be able to join if you are average risk and getting a routine screening colonoscopy.
This study is testing a new blood test to find colorectal cancer early. You may be able to join if you are about to have a colonoscopy or surgery for a suspected tumor.
This study checks whether a blood test can help identify colorectal cancer or precancerous growths. You would have a planned colonoscopy, and researchers compare the blood test results to what the colonoscopy finds.
This study is evaluating PreveCol, a new second-line stool test for people aged 50–69 who had a positive FIT/FOBT result and are already scheduled for a colonoscopy. It aims to find out if this test can help detect colorectal cancer earlier.
Hear when a new Colorectal Cancer (CRC) Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.